HIV and hepatitis coinfection

Impact of pegylated interferon alfa-2b and ribavirin on liver fibrosis in patients with chronic hepatitis C.

This is the study of 3,000 patients receiving one of 10 IFN based regimens assessing impact of PEG-IFN/RBV in fibrosis and activity in responders and nonresponders, and cirrhotics.

The findings are interesting and were reported in Gastroenterology. This report contains tables and charts from the published study.

Links to other websites are current at date of posting but not maintained.